RETRACTION: Probiotics Fermentation Technology, a Novel Kefir Product, Ameliorates Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimer's Disease in Mice.

Cellular Longevity OMA

Open source

DOI
10.1155/omcl/9795039
Published
2026
Container
Oxidative medicine and cellular longevity
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/omcl/9795039,
  title = {RETRACTION: Probiotics Fermentation Technology, a Novel Kefir Product, Ameliorates Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimer's Disease in Mice.},
  author = {Cellular Longevity OMA},
  year = {2026},
  journal = {Oxidative medicine and cellular longevity},
  doi = {10.1155/omcl/9795039},
  url = {https://doi.org/10.1155/omcl/9795039}
}

RIS

TY  - JOUR
TI  - RETRACTION: Probiotics Fermentation Technology, a Novel Kefir Product, Ameliorates Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimer's Disease in Mice.
AU  - Cellular Longevity OMA
PY  - 2026
JO  - Oxidative medicine and cellular longevity
DO  - 10.1155/omcl/9795039
UR  - https://doi.org/10.1155/omcl/9795039
ER  - 

APA

OMA, C. L. (2026). RETRACTION: Probiotics Fermentation Technology, a Novel Kefir Product, Ameliorates Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimer's Disease in Mice.. Oxidative medicine and cellular longevity. https://doi.org/10.1155/omcl/9795039

Source records